<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>TTD metabolites in plasma is_biomarker_for Colorectal Cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>TTD metabolites in plasma</strong>
  <span class="pred">&mdash;is_biomarker_for&rarr;</span>
  <strong>Colorectal Cancer</strong>
</div>
<div class="entity-id">UNKNOWN:ttd metabolites in plasma &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: Curated (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 22.73<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (Curated, 1 paper)<br>Score from 36 citations: <strong>22.73</strong><br><span style="color:#888">15&times; extends (+14.39) &middot; 20&times; supports (+8.04) &middot; 1&times; applies (+0.30)</span></div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="Curated"></span><span>Curated</span><a href="https://doi.org/10.1021/acs.analchem.8b05177">10.1021/acs.analchem.8b05177</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 36 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>20</span><span class="cite-subtotal">&middot; +8.04</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Tryptophan metabolism pathway — predicts → Colorectal Cancer Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/b5a28b52535da3b5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">SNP in IDO1 gene — predicts → Colorectal Cancer Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/3c532898e577f272.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Purine metabolism pathway — predicts → 5-Year Overall Survival in Colorectal Cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/46632f0d7be0301c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Metabolomic pathway activity score — distinguishes → Colorectal Cancer Recurrence vs. Non-Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/91e61fee63c809b1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">pre-therapeutic serum metabolites — predicts → nCRT-induced diarrhea</span><span class="cite-claim-weight">+0.50</span><a href="../claim/750712ea3aa72b8c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">acyl carnitines — correlates_with → sex disparity in nCRT-induced diarrhea</span><span class="cite-claim-weight">+0.50</span><a href="../claim/b0934b7e792b3dc7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phenylalanine metabolism — predicts → nCRT therapeutic response in rectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/37cf9aa341c8f61b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">essential amino acid metabolism — predicts → nCRT therapeutic response in rectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/810a7e4299423912.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">neoadjuvant chemoradiotherapy (nCRT) — causes → serum metabolic alterations</span><span class="cite-claim-weight">+0.50</span><a href="../claim/6da331b88e6eff21.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Threonine — decreases → Growing Colorectal Adenoma</span><span class="cite-claim-weight">+0.50</span><a href="../claim/bd365130be4f65e9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Asparagine — decreases → Growing Colorectal Adenoma</span><span class="cite-claim-weight">+0.50</span><a href="../claim/a43301deae7cfe9b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Glutamine — decreases → Colorectal Adenoma (unknown growth status)</span><span class="cite-claim-weight">+0.50</span><a href="../claim/439bd153b36e39bd.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Arginine — increases → Low-risk Colorectal Adenoma</span><span class="cite-claim-weight">+0.50</span><a href="../claim/710d9e636774d1cb.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Threonine — distinguishes → Growing Colorectal Adenoma</span><span class="cite-claim-weight">+0.50</span><a href="../claim/5695db62d89a90b9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Glutamine — distinguishes → Growing Colorectal Adenoma</span><span class="cite-claim-weight">+0.50</span><a href="../claim/1e67fc0b8f8a6350.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Combined panel: D-AABA + L-Ala + D-Ala + D-Gln + D-Ser — distinguishes → Colorectal Cancer vs Healthy Controls</span><span class="cite-claim-weight">+0.50</span><a href="../claim/27d577b98e53f32e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Combined panel: D-AABA + D-Ala + D-Gln + D-Ser — distinguishes → Colorectal Cancer vs Healthy Controls</span><span class="cite-claim-weight">+0.50</span><a href="../claim/c51e8d71188dd1ae.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">D-methionine — decreases → Colorectal Cancer (age &gt; 50)</span><span class="cite-claim-weight">+0.50</span><a href="../claim/387f0fc1691bcb5e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">LC-IM-MS lipidomics method — distinguishes → colorectal cancer preoperative vs postoperative plasma</span><span class="cite-claim-weight">+0.50</span><a href="../claim/dad9bf49bb9314ef.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylcholines (PC) — correlates_with → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/6ded24f74a1a4806.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:75px"></span><span>15</span><span class="cite-subtotal">&middot; +14.39</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phenylalanine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+1.20</span><a href="../claim/2b2ddbab069d3634.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">alanine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+6.20</span><a href="../claim/4799c6376c53277f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Kynurenine — is_biomarker_for → Colorectal cancer stage</span><span class="cite-claim-weight">+1.55</span><a href="../claim/15709a5e8bd22547.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Phenylalanine metabolism pathway — predicts → Colorectal Cancer Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/e9fd48260d547a3d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Indole-3-acetic acid — is_biomarker_for → Colorectal Cancer Recurrence</span><span class="cite-claim-weight">+0.01</span><a href="../claim/6511d3c11340ec71.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#d62728"></span><span class="cite-claim-triple">Tryptophan — correlates_with → 5-Year Overall Survival in Colorectal Cancer</span><span class="cite-claim-weight">+0.01</span><a href="../claim/8524ac2670b1fc08.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Asparagine — distinguishes → Growing Colorectal Adenoma</span><span class="cite-claim-weight">+0.60</span><a href="../claim/5634944d08ecb7f8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">D-α-aminobutyric acid — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/5642e770cf570b3f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">D-alanine — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/7ade234f30987916.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">D-glutamine — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/c803b8a43209a47f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">D-serine — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/88dfe84c85051aa0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">D/L-Glutamine ratio — correlates_with → Colorectal Cancer Stage IV vs Stage I</span><span class="cite-claim-weight">+0.60</span><a href="../claim/9e0fe767d557ec3a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">dysregulated lipid species — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/fb85c6b97dd14e46.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">sphingomyelins (SM) — correlates_with → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/5d8a382b7f5526d0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">triglycerides (TG) — correlates_with → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/3fc316eee5182361.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:5px"></span><span>1</span><span class="cite-subtotal">&middot; +0.30</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">pre-therapeutic serum metabolites — predicts → nCRT-induced hematologic toxicity</span><span class="cite-claim-weight">+0.30</span><a href="../claim/86a5fd182917ba6f.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>1079d4ecf1f2ac14</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:ttd metabolites in plasma">UNKNOWN:ttd metabolites in plasma</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
